New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control
Recruiting now
This early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that has spread or cannot be surgically removed. The goal is to find the safest dose and see how well the drug works. About 30 participants who have already tried other treatme…
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC